Vitamin D as a novel nontraditional risk factor for mortality in hemodialysis patients: The need for randomized trials
- 1 October 2007
- journal article
- editorial
- Published by Elsevier in Kidney International
- Vol. 72 (8) , 909-911
- https://doi.org/10.1038/sj.ki.5002544
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Vitamin D levels and early mortality among incident hemodialysis patientsKidney International, 2007
- Mortality risk among hemodialysis patients receiving different vitamin D analogsKidney International, 2006
- Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patientsKidney International, 2006
- Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: A longitudinal studyKidney International, 2006
- Activated Injectable Vitamin D and Hemodialysis SurvivalJournal of the American Society of Nephrology, 2005
- The Prevalence of Nontraditional Risk Factors for Coronary Heart Disease in Patients with Chronic Kidney DiseaseAnnals of Internal Medicine, 2004
- Lower risk for cardiovascular mortality in oral 1 -hydroxy vitamin D3 users in a haemodialysis populationNephrology Dialysis Transplantation, 2004
- Survival of Patients Undergoing Hemodialysis with Paricalcitol or Calcitriol TherapyNew England Journal of Medicine, 2003
- Traditional Cardiovascular Disease Risk Factors in Dialysis Patients Compared with the General PopulationJournal of the American Society of Nephrology, 2002
- Atherosclerotic cardiovascular disease risks in chronic hemodialysis patientsKidney International, 2000